Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.
Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...
14h
GlobalData on MSNLindus Health to partner with CDISC for trial data standardisation using AIBiomedical concepts by CDISC are tailored to ensure data consistency, and link information throughout the data pipeline.
A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
11h
Medpage Today on MSNWhat's the Better Option for High-Risk Prostate Cancer -- Radiation or Surgery?SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Total duration of antibiotic therapy in adults hospitalized with sepsis was significantly shorter among those who received PCT-guided care vs standard care.
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results